SlideShare a Scribd company logo
Presenter-Dr Satya Prasad Mahapatra
Moderator- Dr Dhiraj Kishor
Approach To Ataxia
Ataxia
 Ataxia- from Greek- a- [lack of]+ taxia [order]
 Lack of order
 Of rate, rhythm and force of contraction of
voluntary movements.
 Disorganised, poorly co-ordinated or clumsy
movements
 Traditionally used specifically for lesions
involving;
 Cerebellum or it's pathways
 Proprioceptive sensory pathways
Neural-Localization
 Cerebellum (Most common)
 Sensory pathways (Sensory Ataxia)
 Posterior columns
 Dorsal root ganglia
 Peripheral nerve
 Frontal lobe lesions-fronto-cerebellar fibers
Sensory Ataxia
 Sensory neuropathy and posterior column
disease of the spinal cord (sensory ataxia )
 Loss of distal joint, position sense
 Absence of cerebellar signs such as dysarthria
or nystagmus
 Loss of tendon reflexes
 Corrective effects of vision on sensory ataxia
 Romberg sign
Approach to a case of ataxia
Cortical Ataxia
 FRONTAL LOBE ATAXIA refers to disturbed
coordination due to dysfunction of the
contralateral frontal lobe
 Results from disease involving
frontopontocerebellar fibers en route to synapse
in the pontine nuclei.
 Hyper-reflexia, increased tone and Release
reflexes
 A lesion of the "SUPERIOR PARIETAL LOBULE"
(areas 5 and 7 of Brodmann) may rarely result in
ataxia of the contralateral limbs
Vestibular Dysfunction
 Vertigo is prominent
 Consistent fall to one side
 Nystagmus
 Limb ataxia is absent
 Speech is normal
 Joint position sense is normal
 Patient complains of vertigo rather than
imbalance
Thalamic Ataxia
 Transient ataxia affecting contralateral limbs
after lesion of anterior thalamus
 may see associated motor (pyramidal tract)
signs from involvement of internal capsule
 also can result in asterixis in contralateral
limbs (hemiasterixis)
Approach to a case of ataxia
Approach to a case of ataxia
Clinical features of cerebellar
disease
 Ataxia(appendicular
or axial)
 Dysmetria
 Dyssynergia
 Dysdiadochokinesia
 Rebound
Phenomenon
 Dysarthria
 Tremor
 Titubation
 Increased Postural
Sway
 Hypotonia
 Asthenia
 Nystagmus
Approach to a case of ataxia
Approach to a case of ataxia
Cerebellar Ataxia: Classification
 Acquired or Congenital
 Acute or Sub-acute or Chronic
 Familial or Non familial
 AD or AR or Sporadic
 Ipsilateral signs or Bilateral signs
 Symmetrical or Asymmetrical
 Progressive , Static or Improving, Recurrent/
Episodic
 a/w Higher function, Cranial nerve,Extra-
pyramidal,Peripheral Neuropathy features.
Classification
 Hereditary Group:
 Autosomal Dominant cerebellar Ataxias
 Spinocerebellar ataxia type 1-31, SCA36, Episodic ataxias
 Autosomal Recessive cerebellar Ataxias
 Friedreich's ataxia, Ataxia Telengiectasia, Spastic ataxia
 X-linked cerebellar ataxias
 Fragile X tremor ataxia syndrome
 Mitochondrial
 Myoclonus Epilepsy with Ragged Red Fibers(MERRF)
 Kearns Syre Syndrome (KSS)
Contd...
Cerebellar Ataxia: Classification
(Contd..)
 Non hereditary Group (Sporadic)
 Degenerative progressive
o MSA-C, Idiopathic late onset cerebellar ataxia (IOCA)
 Non-progressive developmental disorders
o Cayman ataxia, Joubert syndrome
 Toxins induced cerebellar degeneration
o Alcohol, Anticonvulsants, Anticancer drugs etc
 Autoimmunity associated
o Multiple sclerosis, Gluten ataxia, Ataxia with anti-GAD Ab
 Paraneoplastic cerebellar degeneration
 Infection mediated
o Post viral infection cerebellitis, Enteric fever,
Adeno/retroviral, malaria, Prions
Cerebellar Ataxia:
Classification (Contd..)
 Developmental malformation(congenital)
o Dandy-Walker Malformation
o Chiari Malformation
o Vermial Agenesis
Diagnostic Approach
 Meticulous evaluation of History
 Age at Onset
 Course of disease
 Drug intake
 Family History
 Personal Social & Occupational information
 Distribution of ataxia
 History of other system illness
 Neurological evaluation
 Ancillary tests
History
 Age at onset
 Childhood
 (congenital, metabolic, infectious, posterior fossa tumors,
hereditary ataxias -more common)
 Adult
 (sporadic ataxias, hereditary ataxias)
 Course of illness(progression)
 Acute
 (metabolic/toxic, infectious, inflammatory, traumatic)
 Subacute
 (metabolic/toxic, infectious, inflammatory,
paraneoplastic, tumor)
 Chronic
 (more likely genetic, degenerative, tumour,
paraneoplastic)
History
 Drug intake:
o Phenytoin, Barbiturates, Lithium, Immunosuppressants(Methotrexate,
Cyclosporine), Chemotherapy(Fluorouracil, Cytarabine )
 Family history:
o Study at least 3 generations
o Consanguinity
o Ethnicity
 Social/Occupational History:
o Alcohol and drug use
o Toxins (Heavy metals, Solvents, Thallium)
o Smoking (Vascular)
History
 Distribution of ataxia:
 Symmetric- Acquired, Hereditary, Degenerative
ataxias
 Asymmetric- Vascular, Tumours, Congenital causes
 Other system illness
 Gastrointestinal symptoms- Gluten ataxia
 Mass lesion- Paraneoplastic ataxias
Harrison 20th
Approach to a case of ataxia
Examination
 Neurological Examination
 Other System Evaluation
 Breast Lump, mass per-abdomen etc.
 Rating Scales
 International Cooperative Ataxia Rating Scale
(ICARS)
 Scale for the assessment and rating of
ataxia(SARA)
 Unified MSA Rating Score (UMSARS)
Ancillary Tests
 Neuro imaging
MRI of brain and spine
 Electro-diagnostic tests
EMG/NCV, EEG, evoked potentials, ERG
 Tests of autonomic dysfunction
Tilt-table tests, sympathetic skin responses and
other tests
 Ophthalmologic examination
Pigmentary retinopathy, Macular degeneration,
Cataracts, Kayser-Fleischer rings
Ancillary Tests
 Genetic tests (available in India)
 AD: SCA 1, 2, 3, 6, 7, 8, 10, 11,12, 14, 17,23 and 28
 AR: FRDA, AOA1 and 2, AT, ARSACS
 X-linked: FXTAS
 Mitochondrial —entire genome sequencing
 Laboratory studies
 Metabolic
 Thyroid function, Vitamins B12, E, and B1, Serum
Cholesterol & Plasma lipoprotein profile, Serum
cholesterol & Urine bile alcohol, phytanic acid, toxicology
screen
 Immune function
 Immunoglobulin levels, Antigliadin antibodies, GAD antibodies,
paraneoplastic antibodies
Ancillary Tests
 Laboratory studies:
 Mitochondrial
 Serum lactate and pyruvate
 Other
 Heavy metals, Peripheral blood smear for acanthocytes, Very
long chain fatty acids, Hexosarninidase A/13, Alpha
fetoprotein & Immunoglobulins, Serum ceruloplasmin & 24
hour urinary copper
 Tissue Studies:
 Muscle, skin and nerve biopsies
 CSF Studies:
 Cell count, glucose and protein, oligoclonal bands, 14-3-3
protein, GAD antibodies, paraneoplastic antibodies, Lactate/
Pyruvate
Hereditary Group:
 Autosomal Dominant cerebellar Ataxias
 Spinocerebellar ataxia type 1-31, SCA36, Episodic ataxias
 Autosomal Recessive cerebellar Ataxias
 Friedreich's ataxia, Ataxia Telengiectasia, Spastic ataxia
 X-linked cerebellar ataxias
 Fragile X tremor ataxia syndrome
 Mitochondrial
 Myoclonus Epilepsy with Ragged Red Fibers(MERRF)
 Kearns Syre Syndrome (KSS)
INTRODUCTION:
 Autosomal Dominant Cerebellar Ataxias
 Clinically and Genetically heterogeneous group of
neurodegenerative disorders.
 Characterised by progressive cerebellar and spinal cord
dysfunction.
 Clinical Features:
 Gait Ataxia, Limb Incoordination, Dysarthria
 Pyramidal and Extrapyramidal involvement
 Occulomotor incordination
 Peripheral Neuropathy
 Retinal degeneration
Approach to a case of ataxia
Approach to a case of ataxia
Clinical Behavior of Common
SCA subtypes:
 Late onset 3rd to 4th decade.
 Diffuse Neuro degeneration
 Predominantly OPCA.
 Variable rates of progression
 Rapid progression: ADCA-I, ADCA-II and ADCA-IV
 Repeat expansion SCA progresses rapidly (except SCA6)
 Higher repeats leads to increase severity of the disease
 Slow progression: ADCA-III (Pure cerebellar forms)
 Variable age at onset
 Anticipation
Approach to a case of ataxia
Approach to a case of ataxia
Approach to a case of ataxia
Hereditary Group:
 Autosomal Dominant cerebellar Ataxias
 Spinocerebellar ataxia type 1-31, SCA36, Episodic ataxias
 Autosomal Recessive cerebellar Ataxias
 Friedreich's ataxia, Ataxia Telengiectasia, Spastic ataxia
 X-linked cerebellar ataxias
 Fragile X tremor ataxia syndrome
 Mitochondrial
 Myoclonus Epilepsy with Ragged Red Fibers(MERRF)
 Kearns Syre Syndrome (KSS)
Autosomal Recessive cerebellar
ataxias
 Introduction:
 Autosomal recessive cerebellar ataxia (ARCAs) are group
of neurodegenerative disorders
 More than 20 genes are known to cause ARCAs
 Infantile-adult onset (generally <25 yrs)
 Cerebellar ataxias with predominant peripheral
neuropathy
 Other features: Cardiac involvement, Muscular
involvement, immunodeficiency, metabolic derangements
etc
 FRDA accounts for the major prevalent ARCA
Friedreich ataxia
 One of the most common hereditary ataxias
 Prevalence: 2 - 4/100,000
 1 in 40,000 in Caucasians populations
 Carrier frequency:1/60-1/100
 Slowly progressive ataxia
 Initial presentation b/w 5-15yrs
 Most are wheelchair bound by late teens- Early 20s
 Scoliosis and pes cavus in 10%
 Heart abnormalities cause premature death in 60% to 80%
 Intronic GAA repeat expansions in the FXN gene
 About 25% of FXN mutation carriers have an atypical
phenotype, such as late onset, for example up to 64 years
 FA with retained tendon reflex The Cochrane Library 2012, Issue 4
Approach to a case of ataxia
Approach to a case of ataxia
Approach to a case of ataxia
Approach to a case of ataxia
Approach to a case of ataxia
Approach to a case of ataxia
Hereditary Group:
 Autosomal Dominant cerebellar Ataxias
 Spinocerebellar ataxia type 1-31, SCA36, Episodic ataxias
 Autosomal Recessive cerebellar Ataxias
 Friedreich's ataxia, Ataxia Telengiectasia, Spastic ataxia
 X-linked cerebellar ataxias
 Fragile X tremor ataxia syndrome
 Mitochondrial
 Myoclonus Epilepsy with Ragged Red Fibers(MERRF)
 Kearns Syre Syndrome (KSS)
X-linked ataxia
 Fragile X associated Tremor-Ataxia syndrome
(FXTAS)
 Major Diagnostic criteria:
 Onset >50 years, M>F
 Neurologic: Gait ataxia, tremor,
 parkinsonism, cognitive decline,
 polyneuropathy, autonomic dysfunction
 Systemic: Premature ovarian failure
 Brain MRI: cerebral/cerebellar atrophy,
T2 signal in middle cerebellar peduncles
 Neuropathology: intranuclear inclusions
in brain and spinal cord
FXTAS Genetic features
 Expanded CGG repeat
 FMR gene
 Chromosome Xq27.3
 Premutation repeat length
 55-200
 Elevated levels FMR1 mRNA
 Toxic gain of function?
 Decreased FMR1 mRNA translational efficiency
Sporadic ataxias
 Multiple system atrophy (MSA)
 Toxins/metabolic
 Paraneoplastic cerebellar degeneration
 Immune-mediated ataxias (gluten, anti-GAD)
 Infectious etiology
Beware of MSA C
 Clinical features:
 Parkinsonism
 Asymmetric, posture/action
tremor, early gait pro lems, +
dopy responsive
 Cerebellar
 Gait and limb ataxia, nystagmus,
dysarthria
 Autonomic
 Orthostatic hypotension, bladder
dysfunction, impotence
 Other
 Hyperreflexia, antecollis,
inspiratory trill r, RBD, dystonia
 Pathology:
 Neuronal cell loss and gliosis
 Glial cytoplasmic inclusions
 No Lewy bodies
Approach to a case of ataxia
Toxins-
Alcohoic Cerebellar
Degeneration(ACD)
• Features:
• Central Ataxia, Lower-limb tremor, Psychosis, Dementia
 Patho-phsyiology:
 Damage to GABA-A receptor, Impaired Glucose metabolism, Vit
B1 deficiency
 MRI:
 Superior cerebellar and cerebral atrophy
 Treatment:
 Alcohol abstinence, Vit B1 replacement
Toxins-
Drug Induced Ataxia-
 Metals – Bismuth, Mercury( paresthesias, resticted visual
defects), Lead
 Solvents- Paint thinners, Toluene( Cognitive defects +
Pyramidal tract signs)
Immune mediated-
Gluten Ataxia:
 Etiology- IgA/IgG Anti-Gliadin Ab, Anti-endomysial Ab and
Ab against Tissue Trans-glutaminase
 Clinical features- 50-60 years onset, Gait Ataxia,
Peripheral neuropathy and gluten sensitivity
 Patho-physiology- Ab targets PC due to share
antigenicity of gluten
 Investigation- Serum-IgA, IgG-antigliadin, anti
endomyseium,TTG, MRI-Cerebellar atrophy and WMH,
Intestinal Biopsy
 Rx- Gluten-free diet, I.V.I.G
Brain(2003),126,685-691
Immune mediated- GAD
ataxia
 Clinical phenotype:
 Onset 20-75 years
 F > M
 Neurologic: Ataxia, nystagmus, dysarthria
 Systemic: Autoimmune disease
 Studies: Anti-GAD Antibodies in serum, CSF
 Brain MRI: cerebellar atrophy in some
 Treatment:
 Steroids, IVIG?
Arch Neurol. 2001;58:22
Paraneoplastic cerebellar
degeneration
 Clinical features:
 Onset precedes neoplasm
 Pancerebellar syndrome: Gait and limb ataxia, dysarthria,
nystagmus, oculomotor dysfunction
 Evolution: Rapid over weeks to months, then stabilize
 Loss of Purkinje cells in the cerebellar cortex, deep
cerebellar nuclei & inferior olivary nuclei
 ? T cell mediated
 PCD can be associated with any cancer, but most common:
o Lung cancer (small-cell)
o Ovarian/Breast carcinoma
o Hodgkins lymphoma
Brain (2003) :126 ; 1409-1418
Paraneoplastic ataxia associated
antibodies:
Brain (2003) :126 ; 1409-1418
When to suspect?
 Age :Late (60 -70 yrs)
 Onset: Sub acute
 Progression: weeks to months then stabilize
 Compatible clinical history
 CSF : Pleocytosis, oligoclonal bands
 MRI: Normal in initial stage, cerebellar atrophy develops
in subsequent months
 FDG-PET Scan: Hypermetabolism
 If initial screening is negative , repeat screening is
advisable
Vitamin deficiency induced Ataxias
INFECTIONS
 VZV in children
 EBV in children
 Bickerstaff's encephalitis(Brainstem-
Opthalmoplegia, ataxia, lower cranial nerve
palsies)
 HIV ( Lymphomas, PML, Infections,
Toxoplasmosis)
 OD (17% classic OD, Ataxic variant of CJD)
 Syphilis (Tabes Dorsalis)
 Whipple's disease
Approach to a case of ataxia
Diagnostic approach to sporadic
adult-onset ataxia
Diagnostic approach to
sporadic adult-onset ataxia
Approach to a case of ataxia
Ataxia with seizures Ataxia with Dementia
 Anti GAD ataxia
 Anti gliadin ataxia
 Mitochondrial
ataxia
 Episodic ataxia
 DRPLA
 SCA 10, SCA 7
 CJD
 Anti gliadin ataxia
 FXTAS syndrme
 SCA 17, 19, 21, 2, 1, 6
 HIV/AIDS
 Mitochondrial disease
 Amyloid ataxia
Ataxia with Neuropathy
 Friedreich ataxia
 AOA2
 Fragile X syndrome
 Vit E deficiency ataxia
 Anti gliadin ataxia
 SCA 12, 18,25,27,8,3,4
 ARSACS
 Refsum disease
 Ataxic sensory neuronopathy of Sjogren
syndrome
Approach to a case of ataxia
Approach to a case of ataxia
APPROACH
CASE
HISTORY
• 40 year old female, right handed
individual, school teacher by occupation from
kGF came with complaints of
CASE
CHIEF COMPLAINTS
• SWAYING forwards and sideways while
getting up from supine posture — 2 yrs
CASE
HOPI
• Apparently normal 2 yrs ago
• She noticed swaying forwards and side ways while
getting up from supine posture and while walking in
narrow passages. gradual onset, slowly progressive
• She started appreciating worsening of swaying
whenever she stood in attention posture with hands
held behind during morning school prayer hours.
• Clumpsiness of hands present in the form of illegible
handwriting but not small in size.
CASE
• No involuntary movements like tremors.
• She is able to sit up and stand without support.
• No change in speech
• She did not complain of tightness or loosening of
limbs
• No h/o dizziness/light headedness/or perception
of movement.
• No h/o tinnitus
CASE
• No back pain or radiating pain
• No difficulty in walking /gripping slippers
• No difficulty in mixing food /reaching out
objects
• Able to differentiate hot /cold water
• Able to feel the floor
• Washbasin sign - negative
CASE
• No h/o altered sensorium,
• No h/o disorientation.
• She was able to precieve the smell normally
• She was able to read the news paper
• No h/o double vision
• No h/o reduced sensations over face and she
was able to chew the food.
CASE
• She was able to close the eyes and no h/o
deviation of ankle of mouth or drooling of
saliva.
• No h/o hard of hearing,no vertigo
• No h/o dysphagia,nasal regurgitation
• No h/o dysarthria
CASE
• She was able to feel the sensation of the
bladder,initiate and control
micturiation,completely evacuate the bladder.
• No h/o bowel incontinence constipation.
• No h/o any altered sweating pattern
CASE
• No h/o fever, headace,seizures
• No h/o loss of appetite / weight loss
• No h/o skin rashes
• No h/o trauma
• No h/o any drug intake/exposure to toxins
• No h/o recent vaccination
Swaying gait
How to utilize history in localization?
Approach to a case of ataxia
Approach to a case of ataxia
How to approach a
patient with sub-acute
unilateral/focal ataxia
Approach to a case of ataxia
How to approach a patient
with chronic unilateral/focal
ataxia
Approach to a case of ataxia
How will you approach a
patient with chronic
symmetrical ataxia?
Approach to a case of ataxia
How will you approach a
patient with symmetrical
sub-acute ataxia
Approach to a case of ataxia
How will you approach a
patient with acute
symmetrical ataxia
Approach to a case of ataxia
Acquired Vs genetic causes of
ataxia
ACQUIRED CAUSES OFATAXIA
Vascular: ischemic stroke, hemonliagic stroke. AV malformations
Infectious: Acute cerebellitis, postinfectious encephalomyelitis"
cerebellar abscess, HIV
Toxic: Alcohol. anticonvulsants, mercury, 5-FU. crtosine arabinoside.
Neoplasticicompressive: Gliomas. ependymomas. meningiomas. basal meningeal
carcinomatosis, craniovertebral junction abnonnalities
Immune: Multiple sclerosis. paraneoplastic syndromes, anti-GAD.. gluten ataxia
Deficiency: Hypothyroidism.. vitamin B1 and B125 vitamin F
GENETIC CAUSES OFATAXIA
Autosomal recessive: FA. AT. AVED, AOA 1. AOA 2, other inborn errors of
metabolism
Autosomal dominant: SCA types 1 through 28, episodic ataxias (types 1. 2)
Ataxias based on age of onset
Approach to a case of ataxia
Approach to a case of ataxia
Approach to a case of ataxia
Ataxia due to drugs and toxins
What to remember during history?
Drugs
• Anti-epileptics
Phenytion, carbamazepine,
Barbiturates,gabapentin,
topiramate
• Chemotherapeutic agents
5-FU, cisplatin, paclitaxel,
Cyclosporin,methotrexate
• Anti psychotics
lithum
• cardiac amiodarone
• Antibiotics metronidazole
Toxin induced ataxia
• Cocaine and heroin
• Metals: mercury, lead
• Toluene and benzene derivatives: glue paint
• Shell fish
• Eucalyptus oil
• Insecticides: chlordecone,phosphine,carbondi-
sulphide( cellophane
manufacture)
Approach to a case of ataxia
Approach to a case of ataxia
Approach to a case of ataxia
Approach to a case of ataxia
Approach to a case of ataxia
Approach to a case of ataxia

More Related Content

PPTX
Autoimmune encephalitis current concepts
PPTX
Autoimmune encephalitis ppt
PPTX
Approach to ataxia
PPTX
Approach to myopathy
PPT
Ataxia
PPTX
Approach to Peripheral Neuropathy
PPT
frontal lobe anatomy and clinical relevance
PPTX
Approach to Ataxia
Autoimmune encephalitis current concepts
Autoimmune encephalitis ppt
Approach to ataxia
Approach to myopathy
Ataxia
Approach to Peripheral Neuropathy
frontal lobe anatomy and clinical relevance
Approach to Ataxia

What's hot (20)

PPTX
Approach to ataxia
PPT
Interesting cases of young stroke
PPTX
Approach to a patient of spastic paraplegia
PPTX
Approach to leukodystrophy
PPTX
Autoimmune Encephalitis
PPTX
semiological classification of seizure, localisation and lateralisation
PPTX
PCR in neurological diseases
PPTX
Approach to myopathy
PPTX
Autoimmune encephalitis
PPTX
Cortical dysplasia
PPT
Approach to Peripheral Neuropathy
PPTX
Approach to Leukodystrophy
PPTX
Spinocerebellar ataxia
PPT
Approach to cerebellar ataxia
PPTX
Approach to demyelinating diseases
PPTX
Reversible cerebral vasoconstriction syndrome
PPTX
Approach to quadriparesis
PPTX
Sub acute sclerosing panencephalitis
Approach to ataxia
Interesting cases of young stroke
Approach to a patient of spastic paraplegia
Approach to leukodystrophy
Autoimmune Encephalitis
semiological classification of seizure, localisation and lateralisation
PCR in neurological diseases
Approach to myopathy
Autoimmune encephalitis
Cortical dysplasia
Approach to Peripheral Neuropathy
Approach to Leukodystrophy
Spinocerebellar ataxia
Approach to cerebellar ataxia
Approach to demyelinating diseases
Reversible cerebral vasoconstriction syndrome
Approach to quadriparesis
Sub acute sclerosing panencephalitis
Ad

Similar to Approach to a case of ataxia (20)

PPTX
Approach to ataxia
PPTX
PPTX
PPT
03 01-06 approach to ataxia
PDF
parkinsonism-180214104126.pdf
PPTX
Ataxia.pptx dbdhndjsjsjdkjzjxjdbfbxnzndndnxj
PPTX
Parkinsonism
PPT
Genetic disorders
PPS
Diagnostic methods
PPT
MOTOR NEURON DISEASE of the neurological system
PPTX
Ataxia for mbbs , bpt , bot , nursing students
PPT
Neuropathology
PPTX
Ataxia
PPTX
ALS_Detailed_Academic_Presentation .pptx
PPTX
Common Neurological Disorders for undergraduates( MBBS, NURSING,PHRMA STUDENT...
PPTX
Parkinsonism & Alzheimer's disease
PPTX
Cerebellar diseases. igbiti
PPTX
CES.pptx
PPSX
Hereditary spastic paraplegia
PPSX
Hereditary spastic paraplegia
Approach to ataxia
03 01-06 approach to ataxia
parkinsonism-180214104126.pdf
Ataxia.pptx dbdhndjsjsjdkjzjxjdbfbxnzndndnxj
Parkinsonism
Genetic disorders
Diagnostic methods
MOTOR NEURON DISEASE of the neurological system
Ataxia for mbbs , bpt , bot , nursing students
Neuropathology
Ataxia
ALS_Detailed_Academic_Presentation .pptx
Common Neurological Disorders for undergraduates( MBBS, NURSING,PHRMA STUDENT...
Parkinsonism & Alzheimer's disease
Cerebellar diseases. igbiti
CES.pptx
Hereditary spastic paraplegia
Hereditary spastic paraplegia
Ad

Recently uploaded (20)

PDF
Transcultural that can help you someday.
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPT
Obstructive sleep apnea in orthodontics treatment
PPTX
ONCOLOGY Principles of Radiotherapy.pptx
PDF
Cardiology Pearls for Primary Care Providers
PPTX
Acid Base Disorders educational power point.pptx
PPTX
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
PPTX
Acute Coronary Syndrome for Cardiology Conference
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
Neuropathic pain.ppt treatment managment
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PDF
شيت_عطا_0000000000000000000000000000.pdf
PPTX
1. Basic chemist of Biomolecule (1).pptx
PDF
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
regulatory aspects for Bulk manufacturing
Transcultural that can help you someday.
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
Obstructive sleep apnea in orthodontics treatment
ONCOLOGY Principles of Radiotherapy.pptx
Cardiology Pearls for Primary Care Providers
Acid Base Disorders educational power point.pptx
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
Acute Coronary Syndrome for Cardiology Conference
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PEADIATRICS NOTES.docx lecture notes for medical students
Neuropathic pain.ppt treatment managment
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
شيت_عطا_0000000000000000000000000000.pdf
1. Basic chemist of Biomolecule (1).pptx
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
Copy of OB - Exam #2 Study Guide. pdf
regulatory aspects for Bulk manufacturing

Approach to a case of ataxia

  • 1. Presenter-Dr Satya Prasad Mahapatra Moderator- Dr Dhiraj Kishor Approach To Ataxia
  • 2. Ataxia  Ataxia- from Greek- a- [lack of]+ taxia [order]  Lack of order  Of rate, rhythm and force of contraction of voluntary movements.  Disorganised, poorly co-ordinated or clumsy movements  Traditionally used specifically for lesions involving;  Cerebellum or it's pathways  Proprioceptive sensory pathways
  • 3. Neural-Localization  Cerebellum (Most common)  Sensory pathways (Sensory Ataxia)  Posterior columns  Dorsal root ganglia  Peripheral nerve  Frontal lobe lesions-fronto-cerebellar fibers
  • 4. Sensory Ataxia  Sensory neuropathy and posterior column disease of the spinal cord (sensory ataxia )  Loss of distal joint, position sense  Absence of cerebellar signs such as dysarthria or nystagmus  Loss of tendon reflexes  Corrective effects of vision on sensory ataxia  Romberg sign
  • 6. Cortical Ataxia  FRONTAL LOBE ATAXIA refers to disturbed coordination due to dysfunction of the contralateral frontal lobe  Results from disease involving frontopontocerebellar fibers en route to synapse in the pontine nuclei.  Hyper-reflexia, increased tone and Release reflexes  A lesion of the "SUPERIOR PARIETAL LOBULE" (areas 5 and 7 of Brodmann) may rarely result in ataxia of the contralateral limbs
  • 7. Vestibular Dysfunction  Vertigo is prominent  Consistent fall to one side  Nystagmus  Limb ataxia is absent  Speech is normal  Joint position sense is normal  Patient complains of vertigo rather than imbalance
  • 8. Thalamic Ataxia  Transient ataxia affecting contralateral limbs after lesion of anterior thalamus  may see associated motor (pyramidal tract) signs from involvement of internal capsule  also can result in asterixis in contralateral limbs (hemiasterixis)
  • 11. Clinical features of cerebellar disease  Ataxia(appendicular or axial)  Dysmetria  Dyssynergia  Dysdiadochokinesia  Rebound Phenomenon  Dysarthria  Tremor  Titubation  Increased Postural Sway  Hypotonia  Asthenia  Nystagmus
  • 14. Cerebellar Ataxia: Classification  Acquired or Congenital  Acute or Sub-acute or Chronic  Familial or Non familial  AD or AR or Sporadic  Ipsilateral signs or Bilateral signs  Symmetrical or Asymmetrical  Progressive , Static or Improving, Recurrent/ Episodic  a/w Higher function, Cranial nerve,Extra- pyramidal,Peripheral Neuropathy features.
  • 15. Classification  Hereditary Group:  Autosomal Dominant cerebellar Ataxias  Spinocerebellar ataxia type 1-31, SCA36, Episodic ataxias  Autosomal Recessive cerebellar Ataxias  Friedreich's ataxia, Ataxia Telengiectasia, Spastic ataxia  X-linked cerebellar ataxias  Fragile X tremor ataxia syndrome  Mitochondrial  Myoclonus Epilepsy with Ragged Red Fibers(MERRF)  Kearns Syre Syndrome (KSS) Contd...
  • 16. Cerebellar Ataxia: Classification (Contd..)  Non hereditary Group (Sporadic)  Degenerative progressive o MSA-C, Idiopathic late onset cerebellar ataxia (IOCA)  Non-progressive developmental disorders o Cayman ataxia, Joubert syndrome  Toxins induced cerebellar degeneration o Alcohol, Anticonvulsants, Anticancer drugs etc  Autoimmunity associated o Multiple sclerosis, Gluten ataxia, Ataxia with anti-GAD Ab  Paraneoplastic cerebellar degeneration  Infection mediated o Post viral infection cerebellitis, Enteric fever, Adeno/retroviral, malaria, Prions
  • 17. Cerebellar Ataxia: Classification (Contd..)  Developmental malformation(congenital) o Dandy-Walker Malformation o Chiari Malformation o Vermial Agenesis
  • 18. Diagnostic Approach  Meticulous evaluation of History  Age at Onset  Course of disease  Drug intake  Family History  Personal Social & Occupational information  Distribution of ataxia  History of other system illness  Neurological evaluation  Ancillary tests
  • 19. History  Age at onset  Childhood  (congenital, metabolic, infectious, posterior fossa tumors, hereditary ataxias -more common)  Adult  (sporadic ataxias, hereditary ataxias)  Course of illness(progression)  Acute  (metabolic/toxic, infectious, inflammatory, traumatic)  Subacute  (metabolic/toxic, infectious, inflammatory, paraneoplastic, tumor)  Chronic  (more likely genetic, degenerative, tumour, paraneoplastic)
  • 20. History  Drug intake: o Phenytoin, Barbiturates, Lithium, Immunosuppressants(Methotrexate, Cyclosporine), Chemotherapy(Fluorouracil, Cytarabine )  Family history: o Study at least 3 generations o Consanguinity o Ethnicity  Social/Occupational History: o Alcohol and drug use o Toxins (Heavy metals, Solvents, Thallium) o Smoking (Vascular)
  • 21. History  Distribution of ataxia:  Symmetric- Acquired, Hereditary, Degenerative ataxias  Asymmetric- Vascular, Tumours, Congenital causes  Other system illness  Gastrointestinal symptoms- Gluten ataxia  Mass lesion- Paraneoplastic ataxias
  • 24. Examination  Neurological Examination  Other System Evaluation  Breast Lump, mass per-abdomen etc.  Rating Scales  International Cooperative Ataxia Rating Scale (ICARS)  Scale for the assessment and rating of ataxia(SARA)  Unified MSA Rating Score (UMSARS)
  • 25. Ancillary Tests  Neuro imaging MRI of brain and spine  Electro-diagnostic tests EMG/NCV, EEG, evoked potentials, ERG  Tests of autonomic dysfunction Tilt-table tests, sympathetic skin responses and other tests  Ophthalmologic examination Pigmentary retinopathy, Macular degeneration, Cataracts, Kayser-Fleischer rings
  • 26. Ancillary Tests  Genetic tests (available in India)  AD: SCA 1, 2, 3, 6, 7, 8, 10, 11,12, 14, 17,23 and 28  AR: FRDA, AOA1 and 2, AT, ARSACS  X-linked: FXTAS  Mitochondrial —entire genome sequencing  Laboratory studies  Metabolic  Thyroid function, Vitamins B12, E, and B1, Serum Cholesterol & Plasma lipoprotein profile, Serum cholesterol & Urine bile alcohol, phytanic acid, toxicology screen  Immune function  Immunoglobulin levels, Antigliadin antibodies, GAD antibodies, paraneoplastic antibodies
  • 27. Ancillary Tests  Laboratory studies:  Mitochondrial  Serum lactate and pyruvate  Other  Heavy metals, Peripheral blood smear for acanthocytes, Very long chain fatty acids, Hexosarninidase A/13, Alpha fetoprotein & Immunoglobulins, Serum ceruloplasmin & 24 hour urinary copper  Tissue Studies:  Muscle, skin and nerve biopsies  CSF Studies:  Cell count, glucose and protein, oligoclonal bands, 14-3-3 protein, GAD antibodies, paraneoplastic antibodies, Lactate/ Pyruvate
  • 28. Hereditary Group:  Autosomal Dominant cerebellar Ataxias  Spinocerebellar ataxia type 1-31, SCA36, Episodic ataxias  Autosomal Recessive cerebellar Ataxias  Friedreich's ataxia, Ataxia Telengiectasia, Spastic ataxia  X-linked cerebellar ataxias  Fragile X tremor ataxia syndrome  Mitochondrial  Myoclonus Epilepsy with Ragged Red Fibers(MERRF)  Kearns Syre Syndrome (KSS)
  • 29. INTRODUCTION:  Autosomal Dominant Cerebellar Ataxias  Clinically and Genetically heterogeneous group of neurodegenerative disorders.  Characterised by progressive cerebellar and spinal cord dysfunction.  Clinical Features:  Gait Ataxia, Limb Incoordination, Dysarthria  Pyramidal and Extrapyramidal involvement  Occulomotor incordination  Peripheral Neuropathy  Retinal degeneration
  • 32. Clinical Behavior of Common SCA subtypes:  Late onset 3rd to 4th decade.  Diffuse Neuro degeneration  Predominantly OPCA.  Variable rates of progression  Rapid progression: ADCA-I, ADCA-II and ADCA-IV  Repeat expansion SCA progresses rapidly (except SCA6)  Higher repeats leads to increase severity of the disease  Slow progression: ADCA-III (Pure cerebellar forms)  Variable age at onset  Anticipation
  • 36. Hereditary Group:  Autosomal Dominant cerebellar Ataxias  Spinocerebellar ataxia type 1-31, SCA36, Episodic ataxias  Autosomal Recessive cerebellar Ataxias  Friedreich's ataxia, Ataxia Telengiectasia, Spastic ataxia  X-linked cerebellar ataxias  Fragile X tremor ataxia syndrome  Mitochondrial  Myoclonus Epilepsy with Ragged Red Fibers(MERRF)  Kearns Syre Syndrome (KSS)
  • 37. Autosomal Recessive cerebellar ataxias  Introduction:  Autosomal recessive cerebellar ataxia (ARCAs) are group of neurodegenerative disorders  More than 20 genes are known to cause ARCAs  Infantile-adult onset (generally <25 yrs)  Cerebellar ataxias with predominant peripheral neuropathy  Other features: Cardiac involvement, Muscular involvement, immunodeficiency, metabolic derangements etc  FRDA accounts for the major prevalent ARCA
  • 38. Friedreich ataxia  One of the most common hereditary ataxias  Prevalence: 2 - 4/100,000  1 in 40,000 in Caucasians populations  Carrier frequency:1/60-1/100  Slowly progressive ataxia  Initial presentation b/w 5-15yrs  Most are wheelchair bound by late teens- Early 20s  Scoliosis and pes cavus in 10%  Heart abnormalities cause premature death in 60% to 80%  Intronic GAA repeat expansions in the FXN gene  About 25% of FXN mutation carriers have an atypical phenotype, such as late onset, for example up to 64 years  FA with retained tendon reflex The Cochrane Library 2012, Issue 4
  • 45. Hereditary Group:  Autosomal Dominant cerebellar Ataxias  Spinocerebellar ataxia type 1-31, SCA36, Episodic ataxias  Autosomal Recessive cerebellar Ataxias  Friedreich's ataxia, Ataxia Telengiectasia, Spastic ataxia  X-linked cerebellar ataxias  Fragile X tremor ataxia syndrome  Mitochondrial  Myoclonus Epilepsy with Ragged Red Fibers(MERRF)  Kearns Syre Syndrome (KSS)
  • 46. X-linked ataxia  Fragile X associated Tremor-Ataxia syndrome (FXTAS)  Major Diagnostic criteria:  Onset >50 years, M>F  Neurologic: Gait ataxia, tremor,  parkinsonism, cognitive decline,  polyneuropathy, autonomic dysfunction  Systemic: Premature ovarian failure  Brain MRI: cerebral/cerebellar atrophy, T2 signal in middle cerebellar peduncles  Neuropathology: intranuclear inclusions in brain and spinal cord
  • 47. FXTAS Genetic features  Expanded CGG repeat  FMR gene  Chromosome Xq27.3  Premutation repeat length  55-200  Elevated levels FMR1 mRNA  Toxic gain of function?  Decreased FMR1 mRNA translational efficiency
  • 48. Sporadic ataxias  Multiple system atrophy (MSA)  Toxins/metabolic  Paraneoplastic cerebellar degeneration  Immune-mediated ataxias (gluten, anti-GAD)  Infectious etiology
  • 49. Beware of MSA C  Clinical features:  Parkinsonism  Asymmetric, posture/action tremor, early gait pro lems, + dopy responsive  Cerebellar  Gait and limb ataxia, nystagmus, dysarthria  Autonomic  Orthostatic hypotension, bladder dysfunction, impotence  Other  Hyperreflexia, antecollis, inspiratory trill r, RBD, dystonia  Pathology:  Neuronal cell loss and gliosis  Glial cytoplasmic inclusions  No Lewy bodies
  • 51. Toxins- Alcohoic Cerebellar Degeneration(ACD) • Features: • Central Ataxia, Lower-limb tremor, Psychosis, Dementia  Patho-phsyiology:  Damage to GABA-A receptor, Impaired Glucose metabolism, Vit B1 deficiency  MRI:  Superior cerebellar and cerebral atrophy  Treatment:  Alcohol abstinence, Vit B1 replacement
  • 52. Toxins- Drug Induced Ataxia-  Metals – Bismuth, Mercury( paresthesias, resticted visual defects), Lead  Solvents- Paint thinners, Toluene( Cognitive defects + Pyramidal tract signs)
  • 53. Immune mediated- Gluten Ataxia:  Etiology- IgA/IgG Anti-Gliadin Ab, Anti-endomysial Ab and Ab against Tissue Trans-glutaminase  Clinical features- 50-60 years onset, Gait Ataxia, Peripheral neuropathy and gluten sensitivity  Patho-physiology- Ab targets PC due to share antigenicity of gluten  Investigation- Serum-IgA, IgG-antigliadin, anti endomyseium,TTG, MRI-Cerebellar atrophy and WMH, Intestinal Biopsy  Rx- Gluten-free diet, I.V.I.G Brain(2003),126,685-691
  • 54. Immune mediated- GAD ataxia  Clinical phenotype:  Onset 20-75 years  F > M  Neurologic: Ataxia, nystagmus, dysarthria  Systemic: Autoimmune disease  Studies: Anti-GAD Antibodies in serum, CSF  Brain MRI: cerebellar atrophy in some  Treatment:  Steroids, IVIG? Arch Neurol. 2001;58:22
  • 55. Paraneoplastic cerebellar degeneration  Clinical features:  Onset precedes neoplasm  Pancerebellar syndrome: Gait and limb ataxia, dysarthria, nystagmus, oculomotor dysfunction  Evolution: Rapid over weeks to months, then stabilize  Loss of Purkinje cells in the cerebellar cortex, deep cerebellar nuclei & inferior olivary nuclei  ? T cell mediated  PCD can be associated with any cancer, but most common: o Lung cancer (small-cell) o Ovarian/Breast carcinoma o Hodgkins lymphoma Brain (2003) :126 ; 1409-1418
  • 57. When to suspect?  Age :Late (60 -70 yrs)  Onset: Sub acute  Progression: weeks to months then stabilize  Compatible clinical history  CSF : Pleocytosis, oligoclonal bands  MRI: Normal in initial stage, cerebellar atrophy develops in subsequent months  FDG-PET Scan: Hypermetabolism  If initial screening is negative , repeat screening is advisable
  • 59. INFECTIONS  VZV in children  EBV in children  Bickerstaff's encephalitis(Brainstem- Opthalmoplegia, ataxia, lower cranial nerve palsies)  HIV ( Lymphomas, PML, Infections, Toxoplasmosis)  OD (17% classic OD, Ataxic variant of CJD)  Syphilis (Tabes Dorsalis)  Whipple's disease
  • 61. Diagnostic approach to sporadic adult-onset ataxia
  • 62. Diagnostic approach to sporadic adult-onset ataxia
  • 64. Ataxia with seizures Ataxia with Dementia  Anti GAD ataxia  Anti gliadin ataxia  Mitochondrial ataxia  Episodic ataxia  DRPLA  SCA 10, SCA 7  CJD  Anti gliadin ataxia  FXTAS syndrme  SCA 17, 19, 21, 2, 1, 6  HIV/AIDS  Mitochondrial disease  Amyloid ataxia
  • 65. Ataxia with Neuropathy  Friedreich ataxia  AOA2  Fragile X syndrome  Vit E deficiency ataxia  Anti gliadin ataxia  SCA 12, 18,25,27,8,3,4  ARSACS  Refsum disease  Ataxic sensory neuronopathy of Sjogren syndrome
  • 69. CASE HISTORY • 40 year old female, right handed individual, school teacher by occupation from kGF came with complaints of
  • 70. CASE CHIEF COMPLAINTS • SWAYING forwards and sideways while getting up from supine posture — 2 yrs
  • 71. CASE HOPI • Apparently normal 2 yrs ago • She noticed swaying forwards and side ways while getting up from supine posture and while walking in narrow passages. gradual onset, slowly progressive • She started appreciating worsening of swaying whenever she stood in attention posture with hands held behind during morning school prayer hours. • Clumpsiness of hands present in the form of illegible handwriting but not small in size.
  • 72. CASE • No involuntary movements like tremors. • She is able to sit up and stand without support. • No change in speech • She did not complain of tightness or loosening of limbs • No h/o dizziness/light headedness/or perception of movement. • No h/o tinnitus
  • 73. CASE • No back pain or radiating pain • No difficulty in walking /gripping slippers • No difficulty in mixing food /reaching out objects • Able to differentiate hot /cold water • Able to feel the floor • Washbasin sign - negative
  • 74. CASE • No h/o altered sensorium, • No h/o disorientation. • She was able to precieve the smell normally • She was able to read the news paper • No h/o double vision • No h/o reduced sensations over face and she was able to chew the food.
  • 75. CASE • She was able to close the eyes and no h/o deviation of ankle of mouth or drooling of saliva. • No h/o hard of hearing,no vertigo • No h/o dysphagia,nasal regurgitation • No h/o dysarthria
  • 76. CASE • She was able to feel the sensation of the bladder,initiate and control micturiation,completely evacuate the bladder. • No h/o bowel incontinence constipation. • No h/o any altered sweating pattern
  • 77. CASE • No h/o fever, headace,seizures • No h/o loss of appetite / weight loss • No h/o skin rashes • No h/o trauma • No h/o any drug intake/exposure to toxins • No h/o recent vaccination
  • 78. Swaying gait How to utilize history in localization?
  • 81. How to approach a patient with sub-acute unilateral/focal ataxia
  • 83. How to approach a patient with chronic unilateral/focal ataxia
  • 85. How will you approach a patient with chronic symmetrical ataxia?
  • 87. How will you approach a patient with symmetrical sub-acute ataxia
  • 89. How will you approach a patient with acute symmetrical ataxia
  • 91. Acquired Vs genetic causes of ataxia
  • 92. ACQUIRED CAUSES OFATAXIA Vascular: ischemic stroke, hemonliagic stroke. AV malformations Infectious: Acute cerebellitis, postinfectious encephalomyelitis" cerebellar abscess, HIV Toxic: Alcohol. anticonvulsants, mercury, 5-FU. crtosine arabinoside. Neoplasticicompressive: Gliomas. ependymomas. meningiomas. basal meningeal carcinomatosis, craniovertebral junction abnonnalities Immune: Multiple sclerosis. paraneoplastic syndromes, anti-GAD.. gluten ataxia Deficiency: Hypothyroidism.. vitamin B1 and B125 vitamin F GENETIC CAUSES OFATAXIA Autosomal recessive: FA. AT. AVED, AOA 1. AOA 2, other inborn errors of metabolism Autosomal dominant: SCA types 1 through 28, episodic ataxias (types 1. 2)
  • 93. Ataxias based on age of onset
  • 97. Ataxia due to drugs and toxins What to remember during history?
  • 98. Drugs • Anti-epileptics Phenytion, carbamazepine, Barbiturates,gabapentin, topiramate • Chemotherapeutic agents 5-FU, cisplatin, paclitaxel, Cyclosporin,methotrexate • Anti psychotics lithum • cardiac amiodarone • Antibiotics metronidazole
  • 99. Toxin induced ataxia • Cocaine and heroin • Metals: mercury, lead • Toluene and benzene derivatives: glue paint • Shell fish • Eucalyptus oil • Insecticides: chlordecone,phosphine,carbondi- sulphide( cellophane manufacture)